Filter by
NewsVitafoods Europe 2021: Breakthrough metabolic clinical health study results and unique partnerships will be revealedLallemand Health Solutions’ team is thrilled to get an occasion to see you in person at the annual nutraceutical gathering Vitafoods Europe, in Geneva Palexpo, from October 5 to 7 2021 to reveal the results of a new breakthrough metabolic […]
Sep 24, 2021
NewsCerebiome® Receives Frost & Sullivan 2021 Best Practices AwardFrost & Sullivan has identified Cerebiome® by Lallemand Health Solutions as the world’s most proven psychobiotic, a major differentiator compared to competitors in the probiotics for mental health space. Lallemand Health Solutions has earned Frost & Sullivan’s 2021 Product Leadership […]
Sep 15, 2021
NewsLallemand Health Solutions Opens the SEMiPyP Congress with Innovative Metabolic Health Study ResultsBrunella Gonzalez Cautela, M.Sc.A. Clinical Research Specialist at the Rosell® Institute from Microbiome and Probiotics by Lallemand, will open the Sociedad Española de MICROBIOTA, Probióticos y Prebióticos (SEMiPyP) congress, which will be held from September 15 to 18, 2021, in […]
Sep 14, 2021
NewsHealth Canada confirms ROSELLA can maintain a healthy vaginal microbiomeLallemand Health Solutions’ convenient orally administered probiotic shown to support women’s intimate health, L. plantarum ROSELLA[1], has gained new indications from Health Canada, recognizing its capacity to help support a healthy vaginal microbiome. More precisely the claims obtained are: Source […]
Sep 8, 2021
NewsInspiring scientific schedule for the 11th Probiotics, Prebiotics and New Foods conferenceBrunella Gonzalez Cautela, M.Sc.A. Clinical Research Specialist within the Clinical Program at the Rosell® Institute from Microbiome and Probiotics by Lallemand, will be speaking at the eleventh edition of Probiotics, Prebiotics and New Foods, Nutraceuticals & Botanicals for Nutrition and […]
Sep 6, 2021
NewsIntroducing a new probiotic solution to support weight management effortsLallemand Health Solutions’ rising star L. rhamnosus HA-114 revealed to improve eating and mood-related behaviors in overweight adults who were undergoing diet-induced weight loss in a new breakthrough study. The results of this recent randomized, double-blind, placebo-controlled clinical trial highlight […]
Sep 1, 2021
News“Healthy ageing and probiotics” free webinarSylvie Binda, Lallemand Health Solutions R&D Director for Microbiome Program and Bioprocess and Galenic Center, invites you to the “Healthy ageing and probiotics” free webinar, taking place on Tuesday 13 July 2021 at 15:00 CET that she will have the […]
Jul 8, 2021
NewsLallemand Health Solutions new active member of Alliance Promotion MicrobioteLallemand Health Solutions joins up to support the mission of the Alliance Promotion Microbiote, a newly formed association to place the microbiome at the heart of diagnostic and therapeutic strategies for better health. This initiative brings together key players in […]
Jun 27, 2021
NewsLallemand Steps in to Support COVAX-UNICEF Campaign with a $US 100,000 donationLallemand contributes to the unprecedented global COVID-19 vaccination campaign via the COVAX Facility with a $US 100,000 donation to UNICEF Canada. With over 4,500 employees on five continents and a worldwide presence, Lallemand has also set up a global dollar-for-dollar […]
Jun 21, 2021
NewsLafti® L10 gains innovative Canadian health claims as an antioxidant probioticLallemand Health Solutions has gained new indications for its documented EXPERT’Biotic™ L. helveticus Lafti® L10 from Health Canada recognizing its antioxidant properties, with a specific focus for athletes’ health. Lafti® L10 new Canadian health claims confirms its antioxidant potential: “Source […]
Jun 16, 2021